Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cancer Gene Therapy|January 8, 2021
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switchWalid Warda, Mathieu Neto Da Rocha, Rim Trad, et al.Frontiers in Oncology|December 28, 2020
Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical TherapeuticsXavier Roussel, Etienne Daguindau, Ana Berceanu, et al.Gene Therapy|May 12, 2023
RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cellsLucie Bouquet, Elodie Bôle-Richard, Walid Warda, et al.Current Research in Translational Medicine|February 11, 2023
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humansClémentine Nicod, Mathieu Neto da Rocha, Walid Warda, et al.Cancer Research|December 6, 2018
CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T CellsWalid Warda, Fabrice Larosa, Mathieu Neto Da Rocha, et al.Journal for Immunotherapy of Cancer|July 8, 2022
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemiaRim Trad, Walid Warda, Vincent Alcazer, et al.Journal of Translational Medicine|June 22, 2021
Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patientsRafik Haderbache, Walid Warda, Eric Hervouet, et al.Pageof 1